Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
New Taipei City, 23142, Taiwan
NCT Number: NCT03068767
149 HBV carriers with inadequate serum vitamin D levels were randomized to two groups: one is supplied with vitamin D and another without as controls. The markers of HBV replication were compared before and after treatment.
Looking for future studies?
Notify Me20 year and older
All sexes
Interventional
Not applicable
New Taipei City, 23142, Taiwan
This is a randomized case-control trial. A total of 149 HBV carriers with inadequate vitamin D (< 30 ng/mL) level were enrolled. They were randomly divided to two groups: one group receiving vitamin D supplement (1600 IU/day) for 2 months and another group as controls. The serum vitamin D, HBV DNA and qHBsAg levels were measured at baseline and after vitamin D supplement. Whether HBV DNA and qHBsAg have significant change after vitamin D supplement can be determined.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: baseline, after 2-month vitamin D supplement
the serum HBV DNA levels were measured in CH-B patients before and after 2-month vitamin D supplement
Time frame: baseline, after 2-month vitamin D supplement
The serum qHBsAg levels were measured before and after 2-month vitamin D supplement
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Other
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01581554
Blood-Borne Infections, Chronic Hepatitis B e Antigen Negative
Bethesda, Maryland, United States
View Trial DetailsNCT04749368
Blood-Borne Infections, Chronic Disease
Kingswood, New South Wales, Australia
View Trial DetailsNCT00004850
Blood-Borne Infections, Communicable Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT06422767
Blood-Borne Infections, Communicable Diseases
Austin, Texas, United States
View Trial Details